Treatment of alloimmune neonatal neutropenia with granulocyte colony-stimulating factor

J Pediatr. 1994 Dec;125(6 Pt 1):948-51. doi: 10.1016/s0022-3476(05)82014-1.

Abstract

Despite numerous attempts to increase the neutrophil count of infants with alloimmune neonatal neutropenia, no therapy has been consistently effective. We describe two infants with alloimmune neutropenia who had a rapid and prolonged increase in neutrophil number after treatment with granulocyte colony-stimulating factor (G-CSF). Patient 1 had antibody directed against the neutrophil antigen NA2. He received three daily doses of G-CSF, and within 2 days his neutrophil count increased from 0.350 x 10(9) to 3.584 x 10(9)/L (350 to 3584/mm3). Despite cessation of treatment the neutrophil count remained in the normal range. Patient 2 had antibody to the neutrophil antigen NA1, and received six daily doses of G-CSF. Within 4 days his neutrophil count increased from 0.477 x 10(9) to 4.320 x 10(9)/L (477 to 4320/mm3) and remained in the normal range for 11 days after the last dose of G-CSF. We recommend that treatment with G-CSF be considered for selected infants with alloimmune neutropenia.

Publication types

  • Case Reports

MeSH terms

  • Follow-Up Studies
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • HLA-A1 Antigen / blood
  • HLA-A1 Antigen / immunology
  • HLA-A2 Antigen / blood
  • HLA-A2 Antigen / immunology
  • Humans
  • Immunoglobulin A / blood
  • Immunoglobulin A / immunology
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Immunoglobulin M / blood
  • Immunoglobulin M / immunology
  • Infant, Newborn
  • Isoantigens / blood
  • Isoantigens / immunology
  • Leukocyte Count
  • Male
  • Neutropenia / immunology
  • Neutropenia / therapy*
  • Neutrophils / immunology

Substances

  • HLA-A1 Antigen
  • HLA-A2 Antigen
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • Isoantigens
  • neutrophil-specific antigen NA1, human
  • neutrophil-specific antigen NA2
  • Granulocyte Colony-Stimulating Factor